Investor Relations

(Security Code :4506 TSE Prime)

Pick Up

Apr. 01, 2025	Notice Regarding a Company Split (Simplified Absorption-Type Company Split) of the Asian Business and the Execution of a Share Transfer Agreement and a Shareholders’ Agreement with Marubeni Global Pharma Corporation	Corporate
Mar. 28, 2025	Notice of Transition to Company with an Audit & Supervisory Committee	Corporate
Mar. 28, 2025	Notice Regarding the Transfer of Shares of Subsidiary	Corporate
Mar. 26, 2025	Notice Regarding Refinancing of Existing Borrowings Through a Syndicated Loan	Finances
Mar. 04, 2025	Sumitomo Pharma Announces Changes in Executive Officers and Other Key Positions	Corporate
Mar. 04, 2025	Sumitomo Chemical Announces the New Corporate Business Plan FY2025 - FY2027	Corporate

May 13, 2025	FY2024 financial results announcement, Analysts, Investors, and the Press conference of financial results FY2024 (planned, 13:00 p.m.)